candesartadura plus 16/12,5 mg tabletten
candesartadura plus 8/12,5 mg tabletten
candesartagen plus 16/12,5 mg tabletten
candesartan-ratiopharm comp. 32 mg/12,5 mg tabletten
candesartan-comp. abz 32 mg/12,5 mg tabletten
candesartan/hydrochlorothiazide mylan 16/12.5 milligram tablets
mcdermott laboratories ltd t/a gerard laboratories - candesartan cilexetil, hydrochlorothiazide - tablets - 16/12.5 milligram - angiotensin ii antagonists and diuretics
candesartan cilexetil and hydrochlorothiazide tablet
solco healthcare llc - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - candesartan cilexetil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with candesartan cilexetil and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joi
caramlo 16 mg/10 mg tabletten
caramlo 8 mg/5 mg tabletten
candesartan/hct heumann 32 mg/25 mg tabletten